STAT1 and Autoimmunity: Increasing evidence indicates (Hu et al., 2021) that dysregulation of the JAK2-STAT1/3 pathway is linked to various cancers, autoimmune disorders, and inflammatory conditions, and it plays a critical role in vivo self-regulation mechanisms.